Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Receivables - Other (2023 - 2024)

Historic Receivables - Other for Ptc Therapeutics (PTCT) over the last 2 years, with Q1 2024 value amounting to $800000.0.

  • Ptc Therapeutics' Receivables - Other changed N/A to $800000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $800000.0, marking a year-over-year change of. This contributed to the annual value of $200000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Ptc Therapeutics reported Receivables - Other of $800000.0 as of Q1 2024.
  • Ptc Therapeutics' 5-year Receivables - Other high stood at $1.4 million for Q3 2023, and its period low was $200000.0 during Q4 2023.